EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引：0

作者：

Saliba, Faouzi ^{[1
]}

De Simone, Paolo ^{[2
]}

Nevens, Frederik ^{[3
]}

De Carlis, Luciano ^{[4
]}

Metselaar, Herold ^{[5
]}

Beckebaum, Susanne ^{[6
]}

Jonas, Sven ^{[7
]}

Sudan, Debra ^{[8
]}

Fischer, Lutz ^{[9
]}

Fung, John J. ^{[10
]}

Jiang, Hai ^{[11
]}

Junge, Guido ^{[12
]}

机构：

[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France

[2] Azienda Osped Univ Pisana, Pisa, Italy

[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[4] Osped Niguarda Ca Granda, Milan, Italy

[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands

[6] Univ Hosp Essen, Essen, Germany

[7] Univ Med Ctr Leipzig, Leipzig, Germany

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1430A / 1431A

页数：2

共 50 条

[41] Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial [J].

De Simone, P. ;

Detry, O. ;

Kintmalm, G. ;

Goss, J. ;

McCormick, P. ;

Rossi, M. ;

Moya, A. ;

Lopez, P. ;

Junge, G. ;

Dong, G. ;

Joseph, D. ;

Duvoux, C. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :169-170

[42] HEPHAISTOS STUDY: DESIGN AND BASELINE DATA FROM EARLY INITIATION OF EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS [J].

Nashan, B. ;

Schemmer, P. ;

Braun, F. ;

Dworak, M. ;

Wimmer, P. ;

Schlitt, H. .

TRANSPLANT INTERNATIONAL, 2015, 28 :316-316

[43] Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients [J].

Saliba, F. ;

De Simone, P. ;

De Carlis, L. ;

Metselaar, H. J. ;

Beckebaum, S. ;

Jonas, S. ;

Sudan, D. ;

Fung, J. ;

Fischer, L. ;

Huang, M. A. ;

Foltys, D. ;

Wang, Y. ;

Sips, C. ;

Lopez, P. ;

Nevens, F. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 :125-126

[44] EFFICACY AND SAFETY OF EARLY USE OF REDUCED TACROLIMUS IN COMBINATION WITH EVEROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVERTRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA [J].

Schemmer, Peter ;

Braun, Felix ;

Schlitt, Hans J. ;

Pascher, Andreas ;

Klein, Christian-Georg ;

Neumann, Ulf ;

Kroeger, Irena ;

Wimmer, Peter ;

Nashan, Bjoern .

TRANSPLANT INTERNATIONAL, 2019, 32 :218-219

[45] Safety and Efficacy Profile of Everolimus With Reduced Tacrolimus in Living Donor Liver Transplant Recipients-12-month Results From the Pivotal H2307 Study [J].

Maluf, Daniel ;

Jeng, Long-Bin ;

Lee, Sung Gyu ;

Soin, Arvinder S. ;

Lee, Wei Chen ;

Emond, Jean ;

Lim, Kieron B. ;

Lopez, Patricia M. ;

Kochuparampil, Jossy ;

Sips, Carole A. ;

Kaneko, Shuhei ;

Grant, David .

HEPATOLOGY, 2017, 66 :901A-901A

[46] Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial [J].

Fung, J. ;

Chavin, K. ;

Moysyuk, Y. ;

Orloff, S. ;

Yantorno, S. ;

Jones, R. ;

Neuhaus, P. ;

Dong, G. ;

Lopez, P. ;

Junge, G. ;

Nevens, F. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :118-118

[47] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART. [J].

Potena, L. ;

Barberini, F. ;

Boffini, M. ;

Maiello, C. ;

Pedrazzini, G. ;

Faggian, G. ;

Gerosa, G. ;

Lilla, P. ;

Marraudino, N. ;

Corda, M. ;

Bernazzali, S. ;

Guarisco, R. ;

Livi, U. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :93-93

[48] Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update [J].

Filipponi, F. ;

De Carlis, L. ;

Metselaar, H. J. ;

Nevens, F. ;

Saliba, F. ;

Junge, G. .

LIVER TRANSPLANTATION, 2010, 16 (06) :S132-S133

[49] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study. [J].

Grant, D. ;

Levy, G. ;

Song, G. ;

Chen, C. ;

Lee, W. ;

Joh, J. ;

Speziale, A. ;

Rauer, B. ;

Wang, Z. ;

Junge, G. ;

Uemoto, S. ;

Suh, K. .

TRANSPLANTATION, 2014, 98 :781-782

[50] The safety and efficacy of sirolimus and cyclosporine versus tacrolimus in de novo orthotopic liver transplant recipients: Results from a pilot study. [J].

Wiesner, RH .

HEPATOLOGY, 2001, 34 (04) :254A-254A

← 1 2 3 4 5 →